The hyperphosphatemia is believed to maintain the elevation of PTH levels in CKD and the dysregulation in the FGF-23/Klotho/PTH axis might lead to the progression of secondary hyperparathyroidism in CKD [12,38], as illustrated in Figure 2. The gene discussed is PTH; the disease is hyperphosphatemia.